CD163 and glioblastoma: CD163+ cells may exhaust T cell responses via Interleukin (IL)-10 released downstream of the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) pathway, which may contribute to the immunosuppressive nature of GBM [13].